Seeking Alpha

EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST

Halfway through 5-year study, ExoDx Prostate Test offers more accurate stratification of high- and low-risk patients compared to standard of care MINNEAPOLIS, May 18, 2023 /PRNewswire/ -- Bio-Techne ...

Human Continuum Appoints Dr. Tsun "Sean" Law MD, MBA as its Chief Executive Officer to Lead the Research and Development Efforts Focused on Next-Generation …

Dr. Law will lead the Company’s efforts to develop and advance an integrated platform of exosome-based therapies, topical ...

Human Continuum Appoints Dr. Omar Khalid Sial, Ph.D., as its Chief Scientific Officer to Spearhead the Development of Innovative Extracellular Vesicle Topical Formulati…

New York, N.Y., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of ...
GEN

GEN Roundup on Exosomes

Exosomes no longer are being ignored. Identified over 30 years ago, these membrane-bound microvesicles have spent many years in the backwater of cell biology, regarded as only the cellular containers ...